Princeton Global Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-20
Closed -$372 – 671
2023
Q3
$372 Hold
20
– – ﹤0.01% 568
2023
Q2
$506 Hold
20
– – ﹤0.01% 555
2023
Q1
$518 Hold
20
– – ﹤0.01% 559
2022
Q4
$0 Sell
20
-162
-89% -$4.37K ﹤0.01% 582
2022
Q3
$5K Hold
182
– – ﹤0.01% 458
2022
Q2
$6K Hold
182
– – ﹤0.01% 458
2022
Q1
$13K Hold
182
– – ﹤0.01% 415
2021
Q4
$17K Hold
182
– – ﹤0.01% 353
2021
Q3
$23K Hold
182
– – 0.01% 330
2021
Q2
$30K Buy
+182
New +$29.5K 0.01% 303
2020
Q3
– Sell
-300
Closed -$57K – 527
2020
Q2
$57K Buy
+300
New +$52.6K 0.02% 248

Other funds holding TDOC

Princeton Global Asset Management's TDOC Position: Q4 2023 in Review

Princeton Global Asset Management sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 20 shares — an estimated $372 sold.

Princeton Global Asset Management first reported a position in TDOC in Q2 2020 and held it in 11 quarters. The position peaked at $57K in Q2 2020. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Princeton Global Asset Management reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Princeton Global Asset Management sold 20 Teladoc Health shares in Q4 2023, an estimated $372.
  • Princeton Global Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 11 quarters.
  • Princeton Global Asset Management's Teladoc Health position peaked at $57K in Q2 2020.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Princeton Global Asset Management's 13F filing for Q4 2023, filed 22 Jan 2024.